Introduction InSight Biopharmaceuticals Ltd. is a privately-owned enterprise that has been at the forefront of the biosimilar industry since 1995. Through strategic partnerships, the company has successfully launched high-value biosimilars in key markets. InSight's technological capabilities and infrastructure allow for comprehensive product development, commercial production, and marketing. The company's diverse portfolio encompasses bulk drug substances and drug products for both biosimilars and complex generics. |